Uromax-D (Tamsulosin & Dutasteride): A Combination Therapy for Benign Prostatic Hyperplasia (BPH)

Uromax-D is a combination of two drugs, Tamsulosin Hydrochloride and Dutasteride. It is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) and for reducing the risk of acute urinary retention and the need for surgery in these patients. The combination provides a dual mechanism of action to address both the dynamic and static components of BPH. It belongs to the therapeutic class of BPH/Urinary retention/Urinary incontinence drugs.

How Uromax-D Works (Pharmacology)

Uromax-D combines two distinct mechanisms of action:

• Tamsulosin: Tamsulosin is an alpha1A-adrenoreceptor blocking agent. It works on the dynamic component of BPH by relaxing the smooth muscles in the prostate and bladder neck, improving urine flow and relieving symptoms. It specifically targets alpha1A and alpha1D receptors, which are predominant in the prostate and bladder.
• Dutasteride: Dutasteride is a dual 5-alpha reductase inhibitor (5ARI). It works on the static component of BPH by inhibiting the conversion of testosterone to dihydrotestosterone (DHT). DHT is a hormone that causes the prostate to grow. By lowering DHT levels, Dutasteride reduces prostate volume over time, addressing the underlying cause of BPH.

Key Indications & Benefits

Uromax-D is indicated for:

• Treatment of moderate to severe symptoms of BPH.
• Reduction of the risk of acute urinary retention and surgery in BPH patients.

Dosage & Administration

The recommended dose is one capsule once daily, taken approximately 30 minutes after the same meal each day. The capsule should be swallowed whole and not chewed or opened. This combination can be used to replace existing dual therapy with Tamsulosin and Dutasteride or can be a direct switch from monotherapy with either drug. Always consult a registered physician for specific dosage instructions.

• Adults (including elderly): One capsule (0.4 mg Tamsulosin & 0.5 mg Dutasteride) once daily.
• Renal impairment: No dosage adjustment is necessary.
• Hepatic impairment: Use with caution in mild to moderate hepatic impairment. It is contraindicated in severe hepatic impairment.

Important Considerations & Warnings

It is crucial to discuss your full medical history with your doctor before taking Uromax-D.

Contraindications:

• Women, children, and adolescents.
• Hypersensitivity to Dutasteride, other 5-alpha reductase inhibitors, Tamsulosin, soya, peanut, or any excipients.
• History of orthostatic hypotension.
• Severe hepatic impairment.

Side Effects:

• Most common: Impotence, decreased libido, breast disorders (enlargement/tenderness), ejaculation disorders, and dizziness.
• The incidence of some sexual side effects is higher with combination therapy than with monotherapy.

Pregnancy & Lactation:

• Contraindicated for use by women. Dutasteride can be absorbed through the skin and may cause developmental issues in a male fetus.
• Fertility: Dutasteride has been shown to reduce sperm count, semen volume, and sperm motility in men. Patients whose partners are or may become pregnant should use a condom to prevent semen exposure.

Precautions & Warnings:

• Cardiac failure: There may be an increased risk of cardiac failure with this combination compared to placebo.
• Prostate Cancer Detection: Dutasteride lowers PSA (Prostate Specific Antigen) levels by about 50%. A new PSA baseline must be established after 6 months of treatment. Any increase from this new baseline should be carefully evaluated as it may indicate prostate cancer.
• Prostate Cancer Risk: A study showed a higher incidence of high-grade prostate cancer in men taking Dutasteride. The relationship is not yet clear. Patients should be regularly monitored for prostate cancer risk.
• Hypotension: The Tamsulosin component can cause a drop in blood pressure, leading to dizziness and weakness, especially when standing up (orthostatic hypotension).
• Intraoperative Floppy Iris Syndrome (IFIS): IFIS has been observed during cataract surgery in patients on Tamsulosin. This can lead to surgical complications. Inform your eye surgeon if you are taking or have previously taken Tamsulosin.
• Breast Neoplasia: Breast cancer has been reported in men taking Dutasteride. Patients should report any breast changes, such as lumps or nipple discharge, to their doctor immediately.
• Leaking Capsule: Women, children, and adolescents should avoid contact with leaking capsules as Dutasteride can be absorbed through the skin.

Drug Interactions:

• Concomitant use with other alpha-1 adrenergic blockers, PDE5 inhibitors (e.g., sildenafil), and cimetidine requires caution due to the risk of enhanced hypotensive effects.

Overdose Effects

• No data is available for overdose of the combination. Overdose with Tamsulosin can cause severe hypotension, vomiting, and diarrhea. Treatment is supportive.
• Overdose with Dutasteride does not have significant safety concerns.

Storage Conditions

Store in a cool and dry place, protected from light.